ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABL • US0028241000

97.81 EUR
+0.26 (+0.27%)
Last: Mar 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While ABL has a great profitability rating, there are some minor concerns on its financial health. ABL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • ABL had positive earnings in the past year.
  • ABL had a positive operating cash flow in the past year.
  • In the past 5 years ABL has always been profitable.
  • ABL had a positive operating cash flow in 4 of the past 5 years.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 16.60%, ABL belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • With an excellent Return On Equity value of 27.43%, ABL belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • ABL has a better Return On Invested Capital (8.88%) than 74.60% of its industry peers.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 8.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of ABL (31.88%) is better than 98.41% of its industry peers.
  • ABL's Profit Margin has improved in the last couple of years.
  • ABL's Operating Margin of 18.29% is fine compared to the rest of the industry. ABL outperforms 76.19% of its industry peers.
  • In the last couple of years the Operating Margin of ABL has grown nicely.
  • ABL has a Gross Margin (56.19%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ABL.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABL is destroying value.
  • ABL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 5.38 indicates that ABL is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ABL (5.38) is better than 88.89% of its industry peers.
  • The Debt to FCF ratio of ABL is 1.87, which is an excellent value as it means it would take ABL, only 1.87 years of fcf income to pay off all of its debts.
  • ABL's Debt to FCF ratio of 1.87 is amongst the best of the industry. ABL outperforms 80.95% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that ABL is not too dependend on debt financing.
  • ABL has a better Debt to Equity ratio (0.23) than 69.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.38
ROIC/WACC0.9
WACC9.91%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
  • ABL has a Current ratio of 1.70. This is comparable to the rest of the industry: ABL outperforms 55.56% of its industry peers.
  • A Quick Ratio of 1.24 indicates that ABL should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.24, ABL is in line with its industry, outperforming 58.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABL.DE Growth Analysis

3.1 Past

  • ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
  • ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
  • The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.13 indicates a rather expensive valuation of ABL.
  • 66.67% of the companies in the same industry are more expensive than ABL, based on the Price/Earnings ratio.
  • ABL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.03.
  • A Price/Forward Earnings ratio of 19.84 indicates a rather expensive valuation of ABL.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
  • ABL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.13
Fwd PE 19.84
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABL is on the same level as its industry peers.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ABL.
Industry RankSector Rank
P/FCF 28.64
EV/EBITDA 18.21
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.92
PEG (5Y)3.1
EPS Next 2Y10.76%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.17%.
  • ABL's Dividend Yield is a higher than the industry average which is at 1.06.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 28.93% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
  • The dividend of ABL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (3/4/2026, 7:00:00 PM)

97.81

+0.26 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap170.08B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target114.26 (16.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend1.88
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-8.74%
PT rev (3m)-9.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 22.13
Fwd PE 19.84
P/S 4.52
P/FCF 28.64
P/OCF 21.73
P/B 3.89
P/tB 9.26
EV/EBITDA 18.21
EPS(TTM)4.42
EY4.52%
EPS(NY)4.93
Fwd EY5.04%
FCF(TTM)3.41
FCFY3.49%
OCF(TTM)4.5
OCFY4.6%
SpS21.64
BVpS25.15
TBVpS10.56
PEG (NY)1.92
PEG (5Y)3.1
Graham Number50.02
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 8.88%
ROICexc 9.99%
ROICexgc 19.14%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.38
F-Score8
WACC9.91%
ROIC/WACC0.9
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABBOTT LABORATORIES / ABL.DE FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.


What is the profitability of ABL stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABL stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 22.13 and the Price/Book (PB) ratio is 3.89.


How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 28.93%.